Treatment with galectin-1 improves myogenic potential and membrane repair in dysferlin-deficient models-Reference-Cited by-同舟云学术

Treatment with galectin-1 improves myogenic potential and membrane repair in dysferlin-deficient models

Published:2020-09-03 Issue:9 Volume:15 Page:e0238441
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Vallecillo-Zúniga Mary L.,Rathgeber Matthew F.,Poulson P. Daniel,Hayes Spencer,Luddington Jacob S.,Gill Hailie N.,Teynor Matthew,Kartchner Braden C.^ORCID,Valdoz Jonard,Stowell Caleb,Markham Ashley R.,Arthur Connie,Stowell Sean,Van Ry Pam M.^ORCID

Funder

Jain Foundation

Department of Chemistry and Biochemistry, Brigham Young University

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference59 articles.

1. Evidence-based guideline summary: diagnosis and treatment of limb-girdle and distal dystrophies: report of the guideline development subcommittee of the American Academy of Neurology and the practice issues review panel of the American Association of Neuromuscular & Electrodiagnostic Medicine;P Narayanaswami;Neurology,2014

2. Limb–girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis;HP Lo;Neuromuscular disorders,2008

3. Muscular dystrophy due to dysferlin deficiency in Libyan Jews-Clinical and genetic features;R Bashir;Brain,2000

4. Dysferlin stabilizes stress-induced Ca2+ signaling in the transverse tubule membrane;JP Kerr;Proc Natl Acad Sci U S A,2013

5. Dysferlin and muscle membrane repair;R Han;Current opinion in cell biology,2007

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiorespiratory fitness and the association with galectin-1 in middle-aged individuals;PLOS ONE;2024-04-05

2. Identification of bazedoxifene for the treatment of LGMD R2 by high throughput screening;2024-03-04

3. The Dysferlinopathies Conundrum: Clinical Spectra, Disease Mechanism and Genetic Approaches for Treatments;Biomolecules;2024-02-21

4. Neuroprotective effects of galectin‑1 on cerebral ischemia/reperfusion injury by regulating oxidative stress;Experimental and Therapeutic Medicine;2024-02-20

5. Pharmacotherapeutic Approaches to Treatment of Muscular Dystrophies;Biomolecules;2023-10-17